Challenges in the Psychopharmacological Management of Very Early-Onset Schizophrenia and Anxiety
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Maynard T, Sikich L, Lieberman J, LaMantia A
. Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia. Schizophr Bull. 2001; 27(3):457-76.
DOI: 10.1093/oxfordjournals.schbul.a006887.
View
2.
Lieberman J, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K
. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry. 2001; 50(11):884-97.
DOI: 10.1016/s0006-3223(01)01303-8.
View
3.
Cannon M, Caspi A, Moffitt T, Harrington H, Taylor A, Murray R
. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002; 59(5):449-56.
DOI: 10.1001/archpsyc.59.5.449.
View
4.
Fish B, Kendler K
. Abnormal infant neurodevelopment predicts schizophrenia spectrum disorders. J Child Adolesc Psychopharmacol. 2005; 15(3):348-61.
DOI: 10.1089/cap.2005.15.348.
View
5.
Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N
. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry. 2009; 48(1):10-8.
PMC: 2664646.
DOI: 10.1097/CHI.0b013e31818b1c63.
View